Cognitive impairment in COVID-19: associations, pathogenesis and treatment questions
Cognitive impairment (CI) can be neurological symptoms or complications of coronavirus disease 2019 (COVID-19). Among the pathogenetic mechanisms, the neurotropicity of the SARS- CoV-2 virus, endothelial dysfunction, coagulopathy, thrombus formation, systemic inflammatory reaction, the consequence...
Main Authors: | V. A. Golovacheva, G. R. Tabeeva, I. V. Kuznetsov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2021-04-01
|
Series: | Неврология, нейропсихиатрия, психосоматика |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/1551 |
Similar Items
-
Cognitive impairment in COVID-19 survivors
by: T. M. Ostroumova, et al.
Published: (2021-02-01) -
Treatment experience of post-COVID cognitive impairment (clinical observation)
by: Yu. V. Zhitkova, et al.
Published: (2022-07-01) -
Current approaches to the diagnosis, prevention, and therapy of cognitive impairments in vascular encephalopathy
by: V.Yu. Lobzin, et al.
Published: (2014-06-01) -
Cognitive complaints and cognitive impairment in patients with chronic daily headache
by: V. A. Golovacheva, et al.
Published: (2017-12-01) -
“I have brain fog…” About cognitive impairment after COVID-19
by: H. Ghabi, et al.
Published: (2022-06-01)